Pricing Log in Create free account

Fate Therapeutics, Inc. (FATE) vs Vanda Pharmaceuticals Inc. (VNDA)

Fate Therapeutics, Inc. and Vanda Pharmaceuticals Inc. are both Biotechnology companies. Fate Therapeutics, Inc. and Vanda Pharmaceuticals Inc. are of similar size ($231.0M and $223.1M). Vanda Pharmaceuticals Inc. grew revenue faster over the last twelve months: 8.11% against −23.4%. Vanda Pharmaceuticals Inc. has the higher net margin (−119.9% vs −1,941.1%) and the lower return on invested capital (−180.2% vs 0.00%). Across the 18 metrics below, Fate Therapeutics, Inc. leads on 10 and Vanda Pharmaceuticals Inc. on 8.

Valuation

Metric FATE VNDA Biotechnology median
P/E n/m n/m 10.60
P/S 34.13 1.01 9.40
P/B 1.44 1.16 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 14.04 0.40 9.02
Earnings yield (57.07%) (121.02%) (32.88%)
Free cash flow yield (47.59%) (64.93%) (23.13%)

Profitability

Metric FATE VNDA Biotechnology median
Gross margin 100.00% 93.59% 68.51%
Operating margin (2,058.08%) (77.59%) 0.00%
Net margin (1,941.09%) (119.87%) 0.00%
Free cash flow margin (1,624.06%) (65.41%) 0.00%
Return on equity (60.75%) (82.55%) (51.96%)
Return on assets (39.89%) (55.89%) (46.06%)
Return on invested capital 0.00% (180.19%) 0.00%

Growth

Metric FATE VNDA Biotechnology median
Revenue growth (TTM) (23.36%) 8.11% 6.76%
EPS growth (last fiscal year) 29.88% (1,033.33%) 29.88%
Revenue growth, 5-year CAGR (26.71%) (2.73%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FATE VNDA Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 4.85 1.54 4.97
Net debt to EBITDA 1.47 1.84 1.01

Dividend

Metric FATE VNDA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric FATE VNDA Biotechnology median
Market cap 223.08m 230.99m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack